271 related articles for article (PubMed ID: 22795817)
1. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation.
Vaziri ND
Am J Med; 2012 Oct; 125(10):951-2. PubMed ID: 22795817
[No Abstract] [Full Text] [Related]
2. The iron story: red smoke and magnetism?
Wish JB
Nephrol News Issues; 2014 Feb; 28(2):2-3. PubMed ID: 24649743
[No Abstract] [Full Text] [Related]
3. Understanding iron: promoting its safe use in patients with chronic kidney failure treated by hemodialysis.
Vaziri ND
Am J Kidney Dis; 2013 Jun; 61(6):992-1000. PubMed ID: 23375852
[TBL] [Abstract][Full Text] [Related]
4. The EPO/iron marriage: counseling needed.
Bralow S
Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
[No Abstract] [Full Text] [Related]
5. [Anemia and renal failure: efficacy of its control].
Fort J
Nefrologia; 2006; 26 Suppl 3():28-32. PubMed ID: 17469424
[No Abstract] [Full Text] [Related]
6. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
Rostoker G; Griuncelli M; Loridon C; Couprie R; Benmaadi A; Bounhiol C; Roy M; Machado G; Janklewicz P; Drahi G; Dahan H; Cohen Y
Am J Med; 2012 Oct; 125(10):991-999.e1. PubMed ID: 22998881
[TBL] [Abstract][Full Text] [Related]
7. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
[No Abstract] [Full Text] [Related]
8. [Treatment with high-dose intravenous iron increases mortality and hospitalization in hemodialysis. The basic idea is more important than the style].
Fernández-Gallego J
Nefrologia; 2005; 25(3):340. PubMed ID: 16053019
[No Abstract] [Full Text] [Related]
9. Non-intravenous approaches to iron therapy in chronic kidney disease: will it improve the benefit-to-risk ratio?
Besarab A
Nephrol News Issues; 2014 Feb; 28(2):12, 14-5. PubMed ID: 24649747
[No Abstract] [Full Text] [Related]
10. Iron overload in the erythropoietin era.
Robbins KC
Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
[TBL] [Abstract][Full Text] [Related]
11. IV Iron: To Give or to Hold in the Presence of Infection in Adults Undergoing Hemodialysis.
Hain D; Braun M
Nephrol Nurs J; 2015; 42(3):279-83; quiz 284. PubMed ID: 26207288
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients.
Kshirsagar AV; Li X
Adv Chronic Kidney Dis; 2019 Jul; 26(4):292-297. PubMed ID: 31477259
[TBL] [Abstract][Full Text] [Related]
13. Toxic effects of IV iron preparations in CKD patients.
Vaziri ND
Nephrol News Issues; 2014 Feb; 28(2):4-5. PubMed ID: 24649744
[TBL] [Abstract][Full Text] [Related]
14. Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
Kapoian T
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S21-8. PubMed ID: 19010258
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for assessment and management of iron deficiency.
Madore F; White CT; Foley RN; Barrett BJ; Moist LM; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S7-S11. PubMed ID: 18668119
[No Abstract] [Full Text] [Related]
16. Iron therapy in chronic kidney disease: Recent changes, benefits and risks.
Ribeiro S; Belo L; Reis F; Santos-Silva A
Blood Rev; 2016 Jan; 30(1):65-72. PubMed ID: 26342303
[TBL] [Abstract][Full Text] [Related]
17. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure, part III.2: treatment of anaemia with iron.
Vaage-Nilsen O
Nephrol Dial Transplant; 2005 Jul; 20(7):1512-3; author reply 1513-4. PubMed ID: 15967789
[No Abstract] [Full Text] [Related]
18. Serial ferritin concentrations in hemodialysis patients receiving intravenous iron.
Kirschbaum B
Clin Nephrol; 2002 Jun; 57(6):452-6. PubMed ID: 12078949
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
Moist LM; Foley RN; Barrett BJ; Madore F; White CT; Klarenbach SW; Culleton BF; Tonelli M; Manns BJ;
Kidney Int Suppl; 2008 Aug; (110):S12-8. PubMed ID: 18668116
[No Abstract] [Full Text] [Related]
20. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
Gallieni M
Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
